As the @humancellatlas project enters its second decade, the question is no longer whether we can map human cells, it is what we will do with the map https://t.co/cRfYrHoRJz
#Throwback
COMMENT | KS Lee, X Su & T Huan
Metabolites are not genes — avoiding the misuse of pathway analysis in metabolomics
https://t.co/YlaTvcsM4Q
DynaVelo: Deep dynamical models of single-cell multiomic velocities predict loss-of-function and rescue perturbations in B cells https://t.co/ngHmBHkOeV
🌐 AI for science just became science diplomacy.
On October 4, the US and 16 other countries, including Japan, South Korea, the UK, Germany and Singapore, endorsed the "Kyoto Vision for a Golden Age of Science" at the STS Forum in Kyoto. I only learned about it today, from a friend. In case you missed it too, here is the short version.
💡 The one-page text covers a lot of what I care about. More diverse funding, from long-term awards to fast grants and prizes. Room for new institutional models. Metascience and reproducibility. AI for science, including autonomous closed-loop discovery. Early investment in young talent.
Much of this I support. Closed-loop, AI-driven experimentation is at the core of what we do in the Theis lab, and funding systems everywhere could use more experimentation themselves.
The declaration builds on the White House report "Science: A New Golden Age" from July, which goes further, for example in rethinking the role of universities. Not trivial. How these ideas translate will differ between national systems. Germany's research ministry, for instance, calls the paper a non-binding basis for discussion and stresses that freedom of research and the independence of science remain non-negotiable.
🌍 For me, the test will be concrete: shared access to compute, data and automated labs, and collaboration across borders. Researchers should help shape what this means in practice.
How do you see it? Will it change how science is funded where you work?
🇩🇪 BMFTR statement: https://t.co/XacVzC1vKp
📄 Kyoto Vision: https://t.co/gq2JrSsE9y
📘 Science: A New Golden Age: https://t.co/ORzxbrXQRq
🇺🇸 White House release: https://t.co/dqMmZBy5FU
#AIforScience #ScienceDiplomacy #Metascience
Excited to share ArchMap, now out in @NatureGenet 🧬
The Human Cell Atlas is building a reference map of every cell in the human body, much as the Human Genome Project gave us a reference for DNA. The real power of a reference is that every new dataset can be read against it, to see what's familiar and what's new.
ArchMap makes that possible for everyone. It's a free, no-code platform where any lab can map its single-cell data onto Human Cell Atlas references, all in the browser.
Built on scArches, ArchMap combines reference mapping, cell-type annotation, uncertainty estimates and collaborative exploration in a single workflow. What excites me most is seeing where new data departs from the reference. In a pulmonary fibrosis example, annotation uncertainty followed by gene-expression analysis points directly to disease-associated cell states.
Huge thanks to Chelsea Bright, Ronald Skorobogat, @MDLuecken , @fabian_theis
Try it: https://t.co/CzKqsHeiri Paper: https://t.co/OfM9vtaLoK
#HumanCellAtlas #SingleCell
Biology does not need models that just describe the world. It needs models that predict what happens when we intervene.
In @CellCellPress Focus on AI in Biology, we lay out how to build biomedical world models, from the data they need to how they should be trained and evaluated.
This review aims to equip researchers with a clear understanding of the current technological landscape and to accelerate the adoption of #SpatialMultiomics methods in biomedical research: https://t.co/9yzH78Fvij
Multiomic Analysis Identifies T-cell Subsets and Mechanisms of Epithelial Interaction in Idiopathic Pulmonary Fibrosis by Haikuo Li @HaikuoLi and colleagues @sjtu1896 & @WashU.
#Throwback
PERSPECTIVE | H Ren, Y Tang & D Zhang
The emerging role of protein l-lactylation in metabolic regulation and cell signalling
https://t.co/vGYVQxXpGL
distinct cell states can be modeled by attractor spaces. every cell state resists external perturbations until it enters a new attractor space. the future of cell state-dependent drug discovery will rely on chaos theory, non-linear dynamics, and attractor spaces to define biology
https://t.co/SfVTNkmDde
My university lab (shanghai jiao tong @sjtu1896 ) just made an “agentic” AI system for diagnosing rare diseases really well. It doesn’t just guess either, it shows traceable reasoning linked to evidence so you can verify.
This specific paper looks really cool too, it works like a team (multiple agents not just one chatbot). It takes messy clinical data and outputs a really nice list with reasons, exactly whats needed!
The west very rarely makes AI for rare diseases because it’s not profitable, so its nice to see China doing lots of work on it. This is the type of work that will help save lives (not chatgpt/claude chatbots..) and its where China is absolutely leading in
Excited to share our new paper in Nature Methods! 🚀
We present iSCALE, a “Google Map” for spatial transcriptomics, scaling cellular-resolution gene expression mapping to large-sized tissues beyond the reach of current platforms. 👉https://t.co/WBvR4Cyirr